Cargando…

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker

Anillin actin-binding protein (ANLN) is crucially involved in cell proliferation and migration. Moreover, ANLN is significantly in tumor progression in several types of human malignant tumors; however, it remains unclear whether ANLN acts through common molecular pathways within different tumor micr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Kejun, Cui, Lei, Li, Cunquan, Tang, Chaofeng, Niu, Yiming, Hao, Ji, Bu, Yang, Chen, Bendong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390797/ https://www.ncbi.nlm.nih.gov/pubmed/35991576 http://dx.doi.org/10.3389/fgene.2022.922472

Ejemplares similares

Comprehensive bioinformatics analysis reveals the prognostic value, predictive value, and immunological roles of ANLN in human cancers
por: Cui, Zhiwei, et al.
Publicado: (2022)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

Prognostic and immunological role of SERPINH1 in pan-cancer
por: Zhong, Huage, et al.
Publicado: (2022)

Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer
por: Lei, Jiangchu, et al.
Publicado: (2022)

PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Deng, Mingxia, et al.
Publicado: (2021)

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
por: Zhang, Wenqing, et al.
Publicado: (2023)

Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker
por: Dong, Qiguan, et al.
Publicado: (2022)

Clinical implication and immunological landscape analyses of ANLN in pan‐cancer: A new target for cancer research
por: Zhang, Lan, et al.
Publicado: (2022)

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors
por: Zhao, Huihui, et al.
Publicado: (2022)

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
por: Xiao, Chen, et al.
Publicado: (2022)

Pan-cancer analysis of super enhancer-induced PRR7-AS1 as a potential prognostic and immunological biomarker
por: Wang, Rui, et al.
Publicado: (2023)

Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers
por: Shi, Yanlong, et al.
Publicado: (2022)

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer
por: Chen, Jianlin, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological role of Fanconi anemia complementation group E
por: Zhou, Zhixian, et al.
Publicado: (2023)

Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate
por: Wang, Zhaotao, et al.
Publicado: (2022)

Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers
por: Zhu, Dong, et al.
Publicado: (2023)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2
por: Xu, Qiqi, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
por: Niu, Hongjuan, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological roles of DEAD-box helicase 5 (DDX5) in human tumors
por: Liu, Shixuan, et al.
Publicado: (2022)

Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
por: Xu, Yingting, et al.
Publicado: (2023)

A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
por: Li, He, et al.
Publicado: (2022)

Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors
por: Liang, Qiuju, et al.
Publicado: (2022)

ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control
por: Dai, Xiaofeng, et al.
Publicado: (2019)

Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer
por: Xie, Hui, et al.
Publicado: (2022)

Systematic pan-cancer analysis identifies cGAS as an immunological and prognostic biomarker
por: Chen, Peng, et al.
Publicado: (2023)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1)
por: Gao, Shuang, et al.
Publicado: (2021)

MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
por: Chen, Dengwang, et al.
Publicado: (2023)

CD155, an onco‐immunologic molecule in human tumors
por: Gao, Jian, et al.
Publicado: (2017)

The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology
por: Hugonnet, Marjolaine, et al.
Publicado: (2021)

Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
por: Zhou, Bolun, et al.
Publicado: (2021)

The value of WNT5A as prognostic and immunological biomarker in pan-cancer
por: Feng, Yingtong, et al.
Publicado: (2022)

Screening ANLN and ASPM as bladder urothelial carcinoma-related biomarkers based on weighted gene co-expression network analysis
por: Yang, Tenghao, et al.
Publicado: (2023)

Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors
por: Eid, Refaat A., et al.
Publicado: (2023)

Genetic Alteration, Prognostic and Immunological Role of Acyl-CoA Synthetase Long-Chain Family Member 4 in a Pan-Cancer Analysis
por: Yu, Yongsheng, et al.
Publicado: (2022)

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
por: Cheng, Xin, et al.
Publicado: (2021)

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
por: Chen, Guoming, et al.
Publicado: (2022)

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022)

Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker
por: Zhang, Rui, et al.
Publicado: (2022)

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
por: Yang, Yaqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rq9pgrhdko03casve1lg0vdqrs